The 20 Best Basal Cell Skin Cancer Doctors in Maryland, US

Richard Pfau is a Dermatologist in Millersville, Maryland. Dr. Pfau is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Acanthosis Nigricans, and Squamous Cell Skin Carcinoma.

Aerlyn Dawn is a Dermatologist in Westminster, Maryland. Dr. Dawn is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Stanley Miller is a Dermatologist in Towson, Maryland. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Jason Marquart is a Dermatologist in Westminster, Maryland. Dr. Marquart is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Edward Primka is a Dermatologist in Leonardtown, Maryland. Dr. Primka is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Bowen's Disease, and Liver Spots.

Cheryl Lonergan is a Dermatologist in Glen Burnie, Maryland. Dr. Lonergan is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Plaque Psoriasis.

Mary Farley is a Dermatologist in Prince Frederick, Maryland. Dr. Farley is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Kelley Redbord is a Dermatologist in Rockville, Maryland. Dr. Redbord is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Deborah Englert is a Dermatologist in Cockeysville, Maryland. Dr. Englert is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Liver Spots, Universal Acquired Melanosis, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus.

David Smack is a Dermatologist in Easton, Maryland. Dr. Smack is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Bowen's Disease.

Lisa Renfro is a Dermatologist in Annapolis, Maryland. Dr. Renfro is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Actinic Keratosis, Basal Cell Skin Cancer, Warts, and Neurocutaneous Melanosis.

Jennifer Cooper is a Dermatologist in Abingdon, Maryland. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Liver Spots, Universal Acquired Melanosis, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus.

Rachel Schleichert is a Dermatologist in Towson, Maryland. Dr. Schleichert has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Pompholyx Eczema.

Ali Hendi is a Dermatologist in Chevy Chase, Maryland. Dr. Hendi is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Stiff Skin Syndrome, Acrogeria, Gottron Type, and Penectomy.

Christopher Dolan is a Dermatologist in Westminster, Maryland. Dr. Dolan is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Zain Syed is a Dermatologist in Lutherville Timonium, Maryland. Dr. Syed is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, Head and Neck Squamous Cell Carcinoma (HNSCC), and Fasciotomy.

James Schiro is a Dermatologist in Hagerstown, Maryland. Dr. Schiro is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Actinic Keratosis, Neurocutaneous Melanosis, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome.

Dr. Elise Ng is as assistant professor of dermatology and the Director of Dermatologic Surgery in the Department of Dermatology at Johns Hopkins. She oversees the Johns Hopkins team of Mohs surgeons across four clinical sites, including the Johns Hopkins Outpatient Center, Greenspring Station, the Medical Pavilion at Howard County, and Sibley Memorial Hospital. She also serves as the Director of the Johns Hopkins Micrographic Surgery and Dermatologic Oncology Fellowship training program and is the clinical co-director of the Melanoma Program at the Sidney Kimmel Comprehensive Cancer Center. Her areas of clinical expertise include Mohs micrographic surgery, complex facial reconstruction following skin cancer surgery, melanoma, cosmetic scar revision, and surgical management of benign and malignant skin lesions. Dr. Ng graduated magna cum laude from Harvard College and was awarded the Harvard College Scholar Award for academic excellence. She received her medical degree from Columbia University College of Physicians and Surgeons and subsequently trained at New York University School of Medicine, one of the nation's top dermatology programs, where she was selected to be chief resident. Following residency, she completed a prestigious fellowship in Mohs micrographic surgery and dermatologic oncology with a focus on advanced reconstruction under the tutelage of one of the leaders in the field at Mount Sinai Hospital in New York. She serves as a reviewer for and her research has been published in premier peer-reviewed journals including Journal of the American Academy of Dermatology and Dermatologic Surgery. Dr. Ng joined the faculty of Johns Hopkins School of Medicine in 2017 and has been consistently recognized as a “Top Doctor” by Baltimore Magazine. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Bowen's Disease.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Squamous Cell Skin Carcinoma, and Pancreaticoduodenectomy.

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.